<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03286400</url>
  </required_header>
  <id_info>
    <org_study_id>TAG 15-03</org_study_id>
    <nct_id>NCT03286400</nct_id>
  </id_info>
  <brief_title>Observational Registry Characterizing the CTAG Device With ACTIVE CONTROL</brief_title>
  <acronym>SURPASS</acronym>
  <official_title>Observational Registry Characterizing the Performance and Feature Use of the GORE® TAG® Conformable Thoracic Stent Graft Featuring ACTIVE CONTROL System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>W.L.Gore &amp; Associates</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>W.L.Gore &amp; Associates</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Collect real-world clinical and device-specific outcomes of the GORE® TAG® Conformable
      Thoracic Stent Graft featuring ACTIVE CONTROL System (CTAG Device with ACTIVE CONTROL) in the
      treatment of aortic disease as part of routine clinical practice.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an observational, prospective, single-arm, post-market registry designed to collect
      real-world clinical and device specific outcomes of the GORE® TAG® Conformable Thoracic Stent
      Graft featuring ACTIVE CONTROL System (CTAG Device with ACTIVE CONTROL) in the treatment of
      aortic disease as part of routine clinical practice. A maximum of 20 clinical investigative
      sites in Europe will participate and up to 125 patients will be enrolled in this registry.
      All consecutive patients meeting protocol selection criteria, consented, with an intention to
      be treated with the CTAG Device with ACTIVE CONTROL will be included and followed through one
      year per institutional standard of care.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 18, 2017</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Procedural Technical Success</measure>
    <time_frame>24 hours</time_frame>
    <description>Successful access to the arterial system, successful deployment at the intended location, patent endoluminal graft, absence of surgical conversion</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment Success at One Month</measure>
    <time_frame>One month</time_frame>
    <description>Freedom from: Type I or III endoleak, rupture of lesion in treated segment, stent graft occlusion, stent graft migration</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Freedom from Major Adverse Events through One Year</measure>
    <time_frame>One year</time_frame>
    <description>Freedom from: Lesion-related mortality, permanent paraplegia or paraparesis, disabling stroke, life-threatening myocardial infarction, new onset of renal failure, respiratory failure, life-threatening bowel ischemia, serious tissue ischemia, major blood loss</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment Success at One Year</measure>
    <time_frame>One year</time_frame>
    <description>Freedom from: Type I or III endoleak, rupture of lesion within treated segment, stent graft occlusion, stent graft migration</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Thoracic Diseases</condition>
  <arm_group>
    <arm_group_label>CTAG Device with ACTIVE CONTROL</arm_group_label>
    <description>All consecutive patients meeting protocol selection criteria, consented, with an intention to be treated with CTAG Device with ACTIVE CONTROL.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CTAG Device with ACTIVE CONTROL</intervention_name>
    <description>Intent to treat with the CTAG Device with ACTIVE CONTROL in the treatment of aortic diseases as part of routine clinical practice.</description>
    <arm_group_label>CTAG Device with ACTIVE CONTROL</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All consecutive patients presenting with an indication for endovascular repair of the
        thoracic aorta are eligible for screening for participation in the registry. Only patients
        who meet all inclusion and no exclusion criteria, and who consent to participate will be
        enrolled.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age ≥ 18 years

          2. Signed informed consent form

          3. Willingness, in the opinion of the investigator, to adhere to standard of care
             follow-up requirements

          4. Surgical indication for TEVAR based on investigator's best medical judgment

          5. Intent to treat with CTAG Device with ACTIVE CONTROL.

        Exclusion Criteria:

          1. Paraplegia or paraparesis at initial presentation

          2. Participation in concurrent research study or registry which may confound registry
             results, unless approved by Sponsor

          3. Prior implantation of a thoracic stent graft

          4. Pregnant or breast-feeding female at time of informed consent signature

          5. Life expectancy &lt; 1 year due to comorbidities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni Torsello, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St Franziskus Hospital GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>KAREN I PARSONS</last_name>
    <phone>+1 928 814 6692</phone>
    <email>kparsons@wlgore.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexandre Figard</last_name>
    <phone>+33 6 08 02 42 91</phone>
    <email>afigard@wlgore.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dittmar Bӧckler, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Köln</name>
      <address>
        <city>Köln</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Brunkwall, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Franziskus Hospital GmbH</name>
      <address>
        <city>Münster</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Torsello, MD, PhD</last_name>
      <phone>+49 251 935 3933</phone>
      <email>giovanni.torsello@ukmuenster.de</email>
    </contact>
    <investigator>
      <last_name>Martin J Austermann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Regensburg</name>
      <address>
        <city>Regensburg</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karin Pfister, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Civili Brescia</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefano Bonardelli, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ospedali dei Colli - Monaldi</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Dialetto, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kakkhee Yeung, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Antonius Hospital</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Heijmen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hence Verhagen, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Central de Asturias</name>
      <address>
        <city>Oviedo</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Santiago de Compostela</name>
      <address>
        <city>Santiago De Compostela</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Lechón Saz, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uppsala University Hospital</name>
      <address>
        <city>Uppsala</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anders Wanhainen, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Örebro University Hospital</name>
      <address>
        <city>Örebro</city>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Artai Pirouzram, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leeds General Infirmary</name>
      <address>
        <city>Leeds</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>St George's Vascular Institute</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ian Loftus, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>St Thomas' London / Guy's Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bijan Modarai, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2017</study_first_submitted>
  <study_first_submitted_qc>September 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2017</study_first_posted>
  <last_update_submitted>May 10, 2018</last_update_submitted>
  <last_update_submitted_qc>May 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CTAG</keyword>
  <keyword>TEVAR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thoracic Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

